Clinical information of the enrolled patients with gliomaa
| 6-Month Follow-Up | Patients (n = 32) | P Value | |
|---|---|---|---|
| Treatment-Related Change (n = 20) | Tumor Progression (n =12) | ||
| WHO grade | .71 | ||
| Grade II | 3 | 2 | |
| Grade III | 6 | 2 | |
| Grade IV | 11 | 8 | |
| No. of male patients | 12 (60%) | 6 (50%) | .59 |
| Age (yr) | 61.5 (36–70) | 59.5 (21–69) | .71 |
| Surgical extent (%) | .46 | ||
| Biopsy or partial resection | 14 | 7 | |
| Gross total resection | 6 | 5 | |
| Postoperative standard radiation therapy or concurrent chemoradiation therapy | 19 | 11 | .55 |
↵a Data are expressed as the median and range for continuous variables. The χ2 test was used to test for differences in categoric variables between the 6-month stable and tumor-progression groups.